Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand
©2016 International Medical Press. Background: Surveillance for mid- and long-term antiretroviral therapy (ART) toxicity in children is important for informing treatment guidelines. We assessed the safety of darunavir (DRV) and atazanavir (ATV), commonly used as second-line protease inhibitors follo...
Saved in:
Main Authors: | Bailey H., Collins I., Childs T., Tostevin A., Goetghebuer T., Valerius N., Königs C., Galli L., Marczynska M., Marques L., Ene L., Voronin E., Okhonskaia L., Noguera-Julian A., Rojo P., Amador J., Naver L., Rudin C., Jourdain G., Tookey P., Giaquinto C., Judd A. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84984677356&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42667 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand
by: Heather Bailey, et al.
Published: (2018) -
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
by: Dinko Rekić, et al.
Published: (2018) -
Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers
by: Lee, L.S., et al.
Published: (2011) -
Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
by: Punyawudho B., et al.
Published: (2017) -
Rilpivirine pharmacokinetics without and with darunavir/ritonavir once daily in adolescents and young adults
by: Foca M., et al.
Published: (2017)